1. Home
  2. RAMP vs RCKT Comparison

RAMP vs RCKT Comparison

Compare RAMP & RCKT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo LiveRamp Holdings Inc.

RAMP

LiveRamp Holdings Inc.

HOLD

Current Price

$37.92

Market Cap

2.3B

Sector

Technology

ML Signal

HOLD

Logo Rocket Pharmaceuticals Inc.

RCKT

Rocket Pharmaceuticals Inc.

N/A

Current Price

$3.34

Market Cap

394.2M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
RAMP
RCKT
Founded
2018
1999
Country
United States
United States
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.3B
394.2M
IPO Year
1994
2014

Fundamental Metrics

Financial Performance
Metric
RAMP
RCKT
Price
$37.92
$3.34
Analyst Decision
Buy
Buy
Analyst Count
5
14
Target Price
$35.60
$29.73
AVG Volume (30 Days)
808.8K
1.4M
Earning Date
05-20-2026
05-04-2026
Dividend Yield
N/A
N/A
EPS Growth
22500.00
26.37
EPS
0.28
0.66
Revenue
$812,940,000.00
N/A
Revenue This Year
$11.18
N/A
Revenue Next Year
$9.09
$64.28
P/E Ratio
$135.04
$5.18
Revenue Growth
9.03
N/A
52 Week Low
$21.71
$2.53
52 Week High
$38.23
$5.45

Technical Indicators

Market Signals
Indicator
RAMP
RCKT
Relative Strength Index (RSI) 60.13 46.97
Support Level $37.65 $3.32
Resistance Level $37.91 $3.37
Average True Range (ATR) 0.14 0.19
MACD -0.04 0.01
Stochastic Oscillator 68.42 47.80

Price Performance

Historical Comparison
RAMP
RCKT

About RAMP LiveRamp Holdings Inc.

LiveRamp Holdings Inc is a technology company that empowers marketers and media owners to deliver and measure marketing performance everywhere it matters. Its data collaboration network seamlessly unites data across advertisers, ad tech platforms, publishers, data providers, and commerce media networks, unlocking insights that deliver transformational consumer experiences and drive measurable business outcomes. The group's platform is engineered for AI agent accessibility, facilitating autonomous data collaboration between the specialized AI agents utilized by customers and partners and the networked platform. It generates the geographic revenue from the United States, followed by Europe, Asia-Pacific ("APAC"), and Other.

About RCKT Rocket Pharmaceuticals Inc.

Rocket Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is focused on the development of gene therapies for rare and devastating pediatric diseases. The pipeline products of the company include RP-A501 for Danaon Disease, RP-L102 for Fanconi Anemia, RP-L201 for Leukocyte Adhesion, RP-L301 for Pyruvate Kinase Deficiency, and RP-L401 for Infantile Malignant Osteopetrosis. It has one reportable segment related to R&D and commercial readiness of its gene therapies.

Share on Social Networks: